DalsnaFinance

EQT to buy molecular testing firm Qiagen for $10.8 billion

Markets Reuters By Reuters 21 Oct 2026 22:48 1 min read
EQT to buy molecular testing firm Qiagen for $10.8 billion

EQT to buy molecular testing firm Qiagen for $10.8 billion  Reuters

Covered in this story

EQT Corporation EQT$54.07-1.37% Qiagen QGEN$50.00+2.25%

Call it yourself

No calls on $EQT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on EQT Corporation →
Read the full story on Reuters → Opens the original article on news.google.com

Summary aggregated from Reuters's public RSS feed. The full reporting belongs to Reuters — please read it on their site.